About this trial
The primary objective of the study is to assess whether optimization of an essential package of health and nutrition services for children under five years of age using vitamin A supplementation touch points (i.e., the implementation model) in selected areas in Kenya and Senegal will increase the coverage of vitamin A supplementation and the coverage of other child health and nutrition services. In addition, the study will also assess the feasibility of the implementation model and the drivers of coverage outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Caregivers of children 12-59 months of age
Health service providers
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Optimized package of child essential health and nutrition services
Other interventionOptimized package of child essential health and nutrition services
Standard package of essential child and nutrition services
Other interventionStandard package of essential child and nutrition services
Treatment groups
Trial outcomes
Primary outcomes
Children who received their age-appropriate VAS
The proportion of children 12-59 months of age who received their age-appropriate VAS
Children who are immunized with measles vaccine
Proportion of children 12-23 months of age who are immunized with one dose of measles (MR1) in Kenya Proportion of children 24-35 months of age who are immunized with the second dose of measles (MR2) in Senegal
Implementation feasibility of new model perceived by health service providers, as assessed by key informant interviews and focus groups
Feasibility of implementation of the new model as perceived by health service providers will be assessed via key informant interviews and focus groups to enquire on: i. Implementation barriers and facilitators ii. Practicality of implementing the optimization model within context and resource availability iii. Program disruption due to the implementation of the model iv. Need for infrastructure to implement the model v. Sustainability of the optimized model. All qualitative information will be triangulated to assess feasibility of implementation of the new model
Fidelity of implementing the new model
Fidelity of implementation will be assessed by measuring: i. The proportion of health facilities preparing and using integrated microplans. ii. The proportion of supportive supervision visits carried out in an integrated way. iii. The proportion of service delivery points providing services in an integrated way Fidelity will be achieved if the three parameters score at least 80%.
Secondary outcomes
Co-coverage of VAS and measles vaccine
Proportion of children 12-23 months of age who have received both their age-appropriate VAS and their age-appropriate vaccines (as measured by measles one) in Kenya Proportion of children 24-35 months of age who have received both their age-appropriate VAS and their age-appropriate vaccines (as measured by measles two) in Senegal
Children screened for malnutrition in the last 6 months
The proportion of children 12-59 months of age who were screened for malnutrition in the last 6 months
Children who have received growth monitoring service
The proportion of children 12-59 months who have received growth monitoring service
Children who have received age-appropriate immunizations
The proportion of children 12-59 months who have received age-appropriate immunizations according to EPI schedule
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Nutrition International
Lead sponsor
Kenya Ministry of Health
Collaborator
Cheikh Anta Diop University, Senegal
Collaborator
Senegal Ministry of Health
Collaborator
Henike Consultants
Collaborator